Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01205061 · ClinicalTrials.gov registry record · NA
Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 162
- Enrollment target
NCT01205061 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 162 participants.
The verdict
NCT01205061, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 162 participants
- Enrollment target
Study Summary
The purpose of the study was to compare the effectiveness and safety of Emervel Deep Lidocaine versus Juvederm Ultra Plus in the treatment of moderate to severe facial wrinkles and folds.
Interventions
- DEVICE Emervel Deep Lidocaine
- DEVICE Juvederm Ultra Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2010-09-27 |
| Est. Completion | 2012-01-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01205061
The ClinicalTrials.gov registry entry for NCT01205061 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Emervel Deep Lidocaine is the first listed.
NCT01205061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01205061 about?
NCT01205061 is a clinical study titled "Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds". The purpose of the study was to compare the effectiveness and safety of Emervel Deep Lidocaine versus Juvederm Ultra Plus in the treatment of moderate to severe facial wrinkles and folds.
What is the current status of trial NCT01205061?
This trial is currently completed. It is a NA study. The enrollment target is 162 participants. The study started on 2010-09-27. Estimated completion is 2012-01-12.
What interventions are being tested in trial NCT01205061?
The interventions under investigation include: Emervel Deep Lidocaine (DEVICE), Juvederm Ultra Plus (DEVICE).
Who is sponsoring clinical trial NCT01205061?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.